Loading…

Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use

Laboratory-based respiratory pathogen (RP) results are often available too late to influence clinical decisions such as hospitalisation or antibiotic treatment due to time delay in transport of specimens and testing schedules. Ward-based i.e. point of care (POC) testing providing rapid results may a...

Full description

Saved in:
Bibliographic Details
Published in:BMC infectious diseases 2017-10, Vol.17 (1), p.671-671, Article 671
Main Authors: Andrews, Denise, Chetty, Yumela, Cooper, Ben S, Virk, Manjinder, Glass, Stephen K, Letters, Andrew, Kelly, Philip A, Sudhanva, Malur, Jeyaratnam, Dakshika
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43
cites cdi_FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43
container_end_page 671
container_issue 1
container_start_page 671
container_title BMC infectious diseases
container_volume 17
creator Andrews, Denise
Chetty, Yumela
Cooper, Ben S
Virk, Manjinder
Glass, Stephen K
Letters, Andrew
Kelly, Philip A
Sudhanva, Malur
Jeyaratnam, Dakshika
description Laboratory-based respiratory pathogen (RP) results are often available too late to influence clinical decisions such as hospitalisation or antibiotic treatment due to time delay in transport of specimens and testing schedules. Ward-based i.e. point of care (POC) testing providing rapid results may alter the clinical management pathway. FilmArray® RP polymerase chain reaction (PCR) systems were placed in three in-patient and out-patient medical areas. Patients presenting with influenza-like illness /upper respiratory tract infection +/- lower RTI were recruited between January-July 2015. FilmArray® POC testing occurred on even days of the month (intervention) or routine, laboratory-based RP PCR testing +/- atypical serology on odd days (control). The primary outcome was length of hospital stay. The secondary outcomes were impact on the use of antimicrobials, readmissions, all-cause mortality, length of ward stay and turn-around time (TAT) (time to result from admission). Of 606 eligible patients, 545 (89.9%) were included; 211 in the control arm and 334 in the intervention arm. 20% of control arm patients and 24% of intervention arm patients had an RP detected. POC testing was not associated with the primary outcome measure, length of stay, but reduced the TAT from 39.5 h to 19.0 h, p 
doi_str_mv 10.1186/s12879-017-2784-z
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_58351e6a883f41ac98f8ec9ae067881b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_58351e6a883f41ac98f8ec9ae067881b</doaj_id><sourcerecordid>1950174612</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43</originalsourceid><addsrcrecordid>eNpdks1u1TAQhSMEoqXwAGyQJTYsCMTOn8OiErrip1IRCMHamsTje10lcWo7hdtn5WGYNOWqRZEVOznnG3t8kuQ5z95wLqu3gQtZN2nG61TUskivHyTHvKh5KvK8eHhnfpQ8CeEiI6EUzePkSDQ0LUp-nPz5MvfRTj3-Zt8239nk7BiZM6wDjyxiiHbcsiv0YQ7Mu5mW-Jr10DoP0fl92kJAfRDakcUd-TxCHHAlgaYKgf2yccc8hsmuThJBF8lhsIvWjeEdA3Y5Q7Cph1G7wS7gEGe9ZxAChnBTYJgWlxtZj-OWiFQgRCDJqGlEO9jOu9ZCz-aAT5NHBvqAz27fJ8nPjx9-bD6n518_nW3en6dd0eQxrfOsNlXRCl00GjOsDNIjuioTWQtZIWWjBZi6FE0uuWi41lqYzIhGc6FNkZ8kZytXO7hQk7cD-L1yYNXNB-e3Cny0XY-qlHnJsQIpc1Nw6BppJHYNYFbVUvKWWKcra5rbAXVHXfTQ34Pe_zPandq6K1VWeUnHIcCrW4B3lzNdjKJWdtj3MKKbg-JNuVx-xQVJX_4nvXCzH6lVi0qWNWWnJBVfVdTZEDyaw2Z4ppYcqjWHirBqyaG6Js-Lu6c4OP4FL_8L-dDgIg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1958572335</pqid></control><display><type>article</type><title>Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Andrews, Denise ; Chetty, Yumela ; Cooper, Ben S ; Virk, Manjinder ; Glass, Stephen K ; Letters, Andrew ; Kelly, Philip A ; Sudhanva, Malur ; Jeyaratnam, Dakshika</creator><creatorcontrib>Andrews, Denise ; Chetty, Yumela ; Cooper, Ben S ; Virk, Manjinder ; Glass, Stephen K ; Letters, Andrew ; Kelly, Philip A ; Sudhanva, Malur ; Jeyaratnam, Dakshika</creatorcontrib><description>Laboratory-based respiratory pathogen (RP) results are often available too late to influence clinical decisions such as hospitalisation or antibiotic treatment due to time delay in transport of specimens and testing schedules. Ward-based i.e. point of care (POC) testing providing rapid results may alter the clinical management pathway. FilmArray® RP polymerase chain reaction (PCR) systems were placed in three in-patient and out-patient medical areas. Patients presenting with influenza-like illness /upper respiratory tract infection +/- lower RTI were recruited between January-July 2015. FilmArray® POC testing occurred on even days of the month (intervention) or routine, laboratory-based RP PCR testing +/- atypical serology on odd days (control). The primary outcome was length of hospital stay. The secondary outcomes were impact on the use of antimicrobials, readmissions, all-cause mortality, length of ward stay and turn-around time (TAT) (time to result from admission). Of 606 eligible patients, 545 (89.9%) were included; 211 in the control arm and 334 in the intervention arm. 20% of control arm patients and 24% of intervention arm patients had an RP detected. POC testing was not associated with the primary outcome measure, length of stay, but reduced the TAT from 39.5 h to 19.0 h, p &lt; 0.001. Only the prescribing decision differed between study arms, p &lt; 0.001. When antivirals were given, the intervention was associated with a reduction in the median time to the first dose of 36 h and allowed appropriate treatment of mycoplasma infection. We found no association between respiratory PCR POC testing and length of stay or most of the secondary outcomes except the antimicrobial prescribing decision. This was probably due to a delay in initiating FilmArray® testing. Despite this, POC testing allowed time-critical antivirals to be given significantly faster, appropriate mycoplasma treatment and results were available considerably faster than routine, laboratory-based testing. Ward-staff of all grades performed POC testing without difficulty suggesting potential use across many divergent healthcare settings. Further studies evaluating the implementation of rapid respiratory PCR POC testing and the effect on length of stay and antimicrobial use are required. ISRCTN10470967 , Retrospectively Registered, 30/6/2015.</description><identifier>ISSN: 1471-2334</identifier><identifier>EISSN: 1471-2334</identifier><identifier>DOI: 10.1186/s12879-017-2784-z</identifier><identifier>PMID: 29017451</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Adults ; Aged ; Anti-Infective Agents - therapeutic use ; Antibiotics ; Antimicrobial agents ; Bacterial infections ; Chlamydia ; Chlamydia pneumoniae ; Clinical outcomes ; Emergency medical care ; Epidemics ; Female ; FilmArray ; Holidays &amp; special occasions ; Hospital costs ; Hospitalization ; Humans ; Illnesses ; Infections ; Infectious diseases ; Influenza ; Influenza, Human - genetics ; Length of stay ; Length of Stay - statistics &amp; numerical data ; Male ; Middle Aged ; Multiplex Polymerase Chain Reaction - methods ; Multiplexing ; Mycoplasma pneumoniae ; Patients ; Pneumonia ; Point of care ; Point-of-Care Testing - statistics &amp; numerical data ; Point-of-Care Testing - utilization ; Respiratory pathogens ; Respiratory syncytial virus ; Respiratory tract ; Respiratory tract diseases ; Respiratory tract infection ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - microbiology ; Respiratory viruses ; Retrospective Studies ; Testing laboratories ; Viruses</subject><ispartof>BMC infectious diseases, 2017-10, Vol.17 (1), p.671-671, Article 671</ispartof><rights>Copyright BioMed Central 2017</rights><rights>The Author(s). 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43</citedby><cites>FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635493/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1958572335?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,38493,43871,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29017451$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Andrews, Denise</creatorcontrib><creatorcontrib>Chetty, Yumela</creatorcontrib><creatorcontrib>Cooper, Ben S</creatorcontrib><creatorcontrib>Virk, Manjinder</creatorcontrib><creatorcontrib>Glass, Stephen K</creatorcontrib><creatorcontrib>Letters, Andrew</creatorcontrib><creatorcontrib>Kelly, Philip A</creatorcontrib><creatorcontrib>Sudhanva, Malur</creatorcontrib><creatorcontrib>Jeyaratnam, Dakshika</creatorcontrib><title>Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use</title><title>BMC infectious diseases</title><addtitle>BMC Infect Dis</addtitle><description>Laboratory-based respiratory pathogen (RP) results are often available too late to influence clinical decisions such as hospitalisation or antibiotic treatment due to time delay in transport of specimens and testing schedules. Ward-based i.e. point of care (POC) testing providing rapid results may alter the clinical management pathway. FilmArray® RP polymerase chain reaction (PCR) systems were placed in three in-patient and out-patient medical areas. Patients presenting with influenza-like illness /upper respiratory tract infection +/- lower RTI were recruited between January-July 2015. FilmArray® POC testing occurred on even days of the month (intervention) or routine, laboratory-based RP PCR testing +/- atypical serology on odd days (control). The primary outcome was length of hospital stay. The secondary outcomes were impact on the use of antimicrobials, readmissions, all-cause mortality, length of ward stay and turn-around time (TAT) (time to result from admission). Of 606 eligible patients, 545 (89.9%) were included; 211 in the control arm and 334 in the intervention arm. 20% of control arm patients and 24% of intervention arm patients had an RP detected. POC testing was not associated with the primary outcome measure, length of stay, but reduced the TAT from 39.5 h to 19.0 h, p &lt; 0.001. Only the prescribing decision differed between study arms, p &lt; 0.001. When antivirals were given, the intervention was associated with a reduction in the median time to the first dose of 36 h and allowed appropriate treatment of mycoplasma infection. We found no association between respiratory PCR POC testing and length of stay or most of the secondary outcomes except the antimicrobial prescribing decision. This was probably due to a delay in initiating FilmArray® testing. Despite this, POC testing allowed time-critical antivirals to be given significantly faster, appropriate mycoplasma treatment and results were available considerably faster than routine, laboratory-based testing. Ward-staff of all grades performed POC testing without difficulty suggesting potential use across many divergent healthcare settings. Further studies evaluating the implementation of rapid respiratory PCR POC testing and the effect on length of stay and antimicrobial use are required. ISRCTN10470967 , Retrospectively Registered, 30/6/2015.</description><subject>Adults</subject><subject>Aged</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacterial infections</subject><subject>Chlamydia</subject><subject>Chlamydia pneumoniae</subject><subject>Clinical outcomes</subject><subject>Emergency medical care</subject><subject>Epidemics</subject><subject>Female</subject><subject>FilmArray</subject><subject>Holidays &amp; special occasions</subject><subject>Hospital costs</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Illnesses</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Influenza</subject><subject>Influenza, Human - genetics</subject><subject>Length of stay</subject><subject>Length of Stay - statistics &amp; numerical data</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multiplex Polymerase Chain Reaction - methods</subject><subject>Multiplexing</subject><subject>Mycoplasma pneumoniae</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Point of care</subject><subject>Point-of-Care Testing - statistics &amp; numerical data</subject><subject>Point-of-Care Testing - utilization</subject><subject>Respiratory pathogens</subject><subject>Respiratory syncytial virus</subject><subject>Respiratory tract</subject><subject>Respiratory tract diseases</subject><subject>Respiratory tract infection</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Respiratory viruses</subject><subject>Retrospective Studies</subject><subject>Testing laboratories</subject><subject>Viruses</subject><issn>1471-2334</issn><issn>1471-2334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdks1u1TAQhSMEoqXwAGyQJTYsCMTOn8OiErrip1IRCMHamsTje10lcWo7hdtn5WGYNOWqRZEVOznnG3t8kuQ5z95wLqu3gQtZN2nG61TUskivHyTHvKh5KvK8eHhnfpQ8CeEiI6EUzePkSDQ0LUp-nPz5MvfRTj3-Zt8239nk7BiZM6wDjyxiiHbcsiv0YQ7Mu5mW-Jr10DoP0fl92kJAfRDakcUd-TxCHHAlgaYKgf2yccc8hsmuThJBF8lhsIvWjeEdA3Y5Q7Cph1G7wS7gEGe9ZxAChnBTYJgWlxtZj-OWiFQgRCDJqGlEO9jOu9ZCz-aAT5NHBvqAz27fJ8nPjx9-bD6n518_nW3en6dd0eQxrfOsNlXRCl00GjOsDNIjuioTWQtZIWWjBZi6FE0uuWi41lqYzIhGc6FNkZ8kZytXO7hQk7cD-L1yYNXNB-e3Cny0XY-qlHnJsQIpc1Nw6BppJHYNYFbVUvKWWKcra5rbAXVHXfTQ34Pe_zPandq6K1VWeUnHIcCrW4B3lzNdjKJWdtj3MKKbg-JNuVx-xQVJX_4nvXCzH6lVi0qWNWWnJBVfVdTZEDyaw2Z4ppYcqjWHirBqyaG6Js-Lu6c4OP4FL_8L-dDgIg</recordid><startdate>20171010</startdate><enddate>20171010</enddate><creator>Andrews, Denise</creator><creator>Chetty, Yumela</creator><creator>Cooper, Ben S</creator><creator>Virk, Manjinder</creator><creator>Glass, Stephen K</creator><creator>Letters, Andrew</creator><creator>Kelly, Philip A</creator><creator>Sudhanva, Malur</creator><creator>Jeyaratnam, Dakshika</creator><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20171010</creationdate><title>Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use</title><author>Andrews, Denise ; Chetty, Yumela ; Cooper, Ben S ; Virk, Manjinder ; Glass, Stephen K ; Letters, Andrew ; Kelly, Philip A ; Sudhanva, Malur ; Jeyaratnam, Dakshika</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adults</topic><topic>Aged</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacterial infections</topic><topic>Chlamydia</topic><topic>Chlamydia pneumoniae</topic><topic>Clinical outcomes</topic><topic>Emergency medical care</topic><topic>Epidemics</topic><topic>Female</topic><topic>FilmArray</topic><topic>Holidays &amp; special occasions</topic><topic>Hospital costs</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Illnesses</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Influenza</topic><topic>Influenza, Human - genetics</topic><topic>Length of stay</topic><topic>Length of Stay - statistics &amp; numerical data</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multiplex Polymerase Chain Reaction - methods</topic><topic>Multiplexing</topic><topic>Mycoplasma pneumoniae</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Point of care</topic><topic>Point-of-Care Testing - statistics &amp; numerical data</topic><topic>Point-of-Care Testing - utilization</topic><topic>Respiratory pathogens</topic><topic>Respiratory syncytial virus</topic><topic>Respiratory tract</topic><topic>Respiratory tract diseases</topic><topic>Respiratory tract infection</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Respiratory viruses</topic><topic>Retrospective Studies</topic><topic>Testing laboratories</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andrews, Denise</creatorcontrib><creatorcontrib>Chetty, Yumela</creatorcontrib><creatorcontrib>Cooper, Ben S</creatorcontrib><creatorcontrib>Virk, Manjinder</creatorcontrib><creatorcontrib>Glass, Stephen K</creatorcontrib><creatorcontrib>Letters, Andrew</creatorcontrib><creatorcontrib>Kelly, Philip A</creatorcontrib><creatorcontrib>Sudhanva, Malur</creatorcontrib><creatorcontrib>Jeyaratnam, Dakshika</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database (Proquest)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andrews, Denise</au><au>Chetty, Yumela</au><au>Cooper, Ben S</au><au>Virk, Manjinder</au><au>Glass, Stephen K</au><au>Letters, Andrew</au><au>Kelly, Philip A</au><au>Sudhanva, Malur</au><au>Jeyaratnam, Dakshika</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use</atitle><jtitle>BMC infectious diseases</jtitle><addtitle>BMC Infect Dis</addtitle><date>2017-10-10</date><risdate>2017</risdate><volume>17</volume><issue>1</issue><spage>671</spage><epage>671</epage><pages>671-671</pages><artnum>671</artnum><issn>1471-2334</issn><eissn>1471-2334</eissn><abstract>Laboratory-based respiratory pathogen (RP) results are often available too late to influence clinical decisions such as hospitalisation or antibiotic treatment due to time delay in transport of specimens and testing schedules. Ward-based i.e. point of care (POC) testing providing rapid results may alter the clinical management pathway. FilmArray® RP polymerase chain reaction (PCR) systems were placed in three in-patient and out-patient medical areas. Patients presenting with influenza-like illness /upper respiratory tract infection +/- lower RTI were recruited between January-July 2015. FilmArray® POC testing occurred on even days of the month (intervention) or routine, laboratory-based RP PCR testing +/- atypical serology on odd days (control). The primary outcome was length of hospital stay. The secondary outcomes were impact on the use of antimicrobials, readmissions, all-cause mortality, length of ward stay and turn-around time (TAT) (time to result from admission). Of 606 eligible patients, 545 (89.9%) were included; 211 in the control arm and 334 in the intervention arm. 20% of control arm patients and 24% of intervention arm patients had an RP detected. POC testing was not associated with the primary outcome measure, length of stay, but reduced the TAT from 39.5 h to 19.0 h, p &lt; 0.001. Only the prescribing decision differed between study arms, p &lt; 0.001. When antivirals were given, the intervention was associated with a reduction in the median time to the first dose of 36 h and allowed appropriate treatment of mycoplasma infection. We found no association between respiratory PCR POC testing and length of stay or most of the secondary outcomes except the antimicrobial prescribing decision. This was probably due to a delay in initiating FilmArray® testing. Despite this, POC testing allowed time-critical antivirals to be given significantly faster, appropriate mycoplasma treatment and results were available considerably faster than routine, laboratory-based testing. Ward-staff of all grades performed POC testing without difficulty suggesting potential use across many divergent healthcare settings. Further studies evaluating the implementation of rapid respiratory PCR POC testing and the effect on length of stay and antimicrobial use are required. ISRCTN10470967 , Retrospectively Registered, 30/6/2015.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>29017451</pmid><doi>10.1186/s12879-017-2784-z</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2334
ispartof BMC infectious diseases, 2017-10, Vol.17 (1), p.671-671, Article 671
issn 1471-2334
1471-2334
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_58351e6a883f41ac98f8ec9ae067881b
source Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Adults
Aged
Anti-Infective Agents - therapeutic use
Antibiotics
Antimicrobial agents
Bacterial infections
Chlamydia
Chlamydia pneumoniae
Clinical outcomes
Emergency medical care
Epidemics
Female
FilmArray
Holidays & special occasions
Hospital costs
Hospitalization
Humans
Illnesses
Infections
Infectious diseases
Influenza
Influenza, Human - genetics
Length of stay
Length of Stay - statistics & numerical data
Male
Middle Aged
Multiplex Polymerase Chain Reaction - methods
Multiplexing
Mycoplasma pneumoniae
Patients
Pneumonia
Point of care
Point-of-Care Testing - statistics & numerical data
Point-of-Care Testing - utilization
Respiratory pathogens
Respiratory syncytial virus
Respiratory tract
Respiratory tract diseases
Respiratory tract infection
Respiratory Tract Infections - drug therapy
Respiratory Tract Infections - microbiology
Respiratory viruses
Retrospective Studies
Testing laboratories
Viruses
title Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T20%3A03%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiplex%20PCR%20point%20of%20care%20testing%20versus%20routine,%20laboratory-based%20testing%20in%20the%20treatment%20of%20adults%20with%20respiratory%20tract%20infections:%20a%20quasi-randomised%20study%20assessing%20impact%20on%20length%20of%20stay%20and%20antimicrobial%20use&rft.jtitle=BMC%20infectious%20diseases&rft.au=Andrews,%20Denise&rft.date=2017-10-10&rft.volume=17&rft.issue=1&rft.spage=671&rft.epage=671&rft.pages=671-671&rft.artnum=671&rft.issn=1471-2334&rft.eissn=1471-2334&rft_id=info:doi/10.1186/s12879-017-2784-z&rft_dat=%3Cproquest_doaj_%3E1950174612%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1958572335&rft_id=info:pmid/29017451&rfr_iscdi=true